This finding has potential implications for Treg ACT in settings of autoimmunity and transplantation: specifically, the preferential outgrowth of TCM from CD226- Tregs may lead to better engraftment efficiency and localization to secondary lymphoid organs where autoimmune priming and graft versus host disease (GvHD) are initiated (45). This evidence concerns the gene CD226 and Autoimmunity.